Drug Discovery Today
MARCH 1, 2024
In July 2022 the SMR hosted a conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’ That conference looked at ongoing developments in pharmaceutical discovery and development, focused on the need for partnerships between large pharmaceutical and new biotech companies to tackle the next generation therapeutic challenges.
Science Daily: Pharmacology News
MARCH 1, 2024
In a recent study, 151 human participants were pitted against ChatGPT-4 in three tests designed to measure divergent thinking, which is considered to be an indicator of creative thought.
Perficient: Drug Development
MARCH 1, 2024
In a dynamic digital landscape, choosing the right provider among the Adobe services landscape is paramount for businesses seeking to maximize their Adobe investments. The selection process can be daunting with a diverse set of providers that vary by size, type of offering, geography, and business scenario differentiation. So where do marketing leaders start?
BioPharma Drive: Drug Pricing
MARCH 1, 2024
The expert committee is discussing whether, for certain older adults, to make a universal recommendation for vaccination, rather than the current policy of “shared decisionmaking.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- New guidance issued Friday by the U.S. Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days. Instead, the CDC recommends.
Science Daily: Pharmacology News
MARCH 1, 2024
Up to a certain point, very luminous stars can have a positive effect on the formation of planets, but from that point on the radiation they emit can cause the material in protoplanetary discs to disperse.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 (HealthDay news) -- More than 1 billion adults and children around the world are now obese, a new global analysis estimates.Nearly 880 million adults now are living with obesity, as well as 159 million children, according to.
BioPharma Drive: Drug Pricing
MARCH 1, 2024
The restructuring comes ahead of a key study readout for Gritstone, which, like Moderna, is developing a type of personalized vaccine for cancer.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2023 -- Bird flu has mutated to spread more easily between birds and marine mammals, increasing the potential risk to humans, a new study warns.Four sea lions, one fur seal and a tern found dead in Argentina all tested positive for.
SCIENMAG: Medicine & Health
MARCH 1, 2024
WHAT: Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men.Researchers now theorize that Black men may have naturally higher.
Covalent Modifiers
MARCH 1, 2024
Daisuke Ogasawara, David Konrad, Zher Yin Tan, Kimberly Carey, Jessica Luo, Sang Joon Won, Haoxin Li, Trever Carter, Kristen DeMeester, Evert Njomen, Stuart Schreiber, Ramnik Xavier, Bruno Melillo, Benjamin Cravatt bioRxiv 2024.02.27.582206; doi: [link] Chemical proteomics enables the global assessment of small molecule-protein interactions in native biological systems and has emerged as a versatile approach for ligand discovery.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- Rodeo riders might make it all look easy, but they’re actually participating in one of the most strenuous sports around, experts say.As such, folks participating in rodeo need to take steps to protect themselves, just as.
Conversations in Drug Development Trends
MARCH 1, 2024
With cost and timelines being two of the most significant factors influencing a study’s progression aside from efficacy and safety, master protocols offer an attractive option for study design. These designs facilitate streamlined trial logistics and centralized governance and create higher-quality data. But how do they work, and when are they appropriate?
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- Once considered harmless by doctors, calcium crystal deposits in the knee joint actually can contribute to worsening arthritis, a new study warns.CT scans have revealed that calcium crystals in the knee can promote joint.
BioPharma Drive: Drug Pricing
MARCH 1, 2024
Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2023 -- A bicycle built for two could be a positive prescription for Parkinson’s patients and their caregivers, a small, preliminary study says.Parkinson’s patients had better overall quality of life, improved mobility, and.
SCIENMAG: Medicine & Health
MARCH 1, 2024
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- Although the pandemic has ended, staffing shortages and employee burnout still plague U.S. nursing homes, a new government report finds.But the problems didn't end there: The report, issued Thursday by the Inspector.
BioPharma Drive: Drug Pricing
MARCH 1, 2024
The cash will be used to advance development of FOG-001, the company’s lead drug that’s now being tested in an early-stage trial for solid tumors.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- Vaping and skipped meals appear to be the main causes of frequent headaches among teens, a new study says.Teens who ate breakfast and dinner with their family had a lower risk of frequent headaches than those who regularly.
Collaborative Drug
MARCH 1, 2024
FDA Approved 55 New Molecular Entities in 2023 Can Ancient Skeletons Give Clues to Modern Medical Mysteries?
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- The adjustment to and from daylight saving time might be a biannual annoyance, but there’s no evidence that it harms a person’s heart health, a new study finds.Data from more than 36 million adults ages 18 and older.
Drug Patent Watch
MARCH 1, 2024
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long… The post Which drugs have supplementary protection certificates in the most countries? appeared first on DrugPatentWatch - Make Better Decisions.
Drugs.com
MARCH 1, 2024
FRIDAY, March 1, 2024 -- An outbreak of mpox (formerly known as monkeypox) across Europe and North America made headlines in 2022. According to data from the U.S. Centers for Disease Control and Prevention, the 2022 outbreak of.
Drug Patent Watch
MARCH 1, 2024
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Abbvie and is included in two NDAs. It is available from two suppliers. There is one patent… The post New patent expiration for Abbvie drug ALPHAGAN P appeared first on DrugPatentWatch - Make Better Decisions.
Agency IQ
MARCH 1, 2024
BY CHELSEY MCINTYRE, PHARMD , KIRSTEN MESSMER, PHD, RAC , COREY JASEPH, MS, RAC , KARI OAKES In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.
Drug Patent Watch
MARCH 1, 2024
Annual Drug Patent Expirations for MIRENA Mirena is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are four patents… The post New patent for Bayer Hlthcare drug MIRENA appeared first on DrugPatentWatch - Make Better Decisions.
Agency IQ
MARCH 1, 2024
BY SCOTT STEPHENS, MPA Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more.
Drug Patent Watch
MARCH 1, 2024
Annual Drug Patent Expirations for SKYLA Skyla is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are six patents… The post New patent for Bayer Hlthcare drug SKYLA appeared first on DrugPatentWatch - Make Better Decisions.
Perficient: Drug Development
MARCH 1, 2024
Perficient would like to announce our very own Mark Hall, Senior Solutions Architect, as the newest Optimizely MVP. Hall is one of 10 outstanding individuals worldwide awarded as a 2024 Winter OMVP. This is Perficient’s eighth OMVP award, solidifying our company with the most OMVPs in North America. Each year, Optimizely awards a select group of individuals the honor of being an Optimizely MVP.
Drug Patent Watch
MARCH 1, 2024
Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are six patents… The post New patent for Bayer Hlthcare drug KYLEENA appeared first on DrugPatentWatch - Make Better Decisions.
Agency IQ
MARCH 1, 2024
BY ALEXANDER GAFFNEY, MS, RAC In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more. The goal: To allow regulatory professionals to better anticipate and prepare for upcoming events and catalysts. Fill out the form to read the full article.
Expert insights. Personalized for you.
113 
Let's personalize your content